Takara Holdings Inc (2531):企業の財務・戦略的SWOT分析

◆英語タイトル:Takara Holdings Inc (2531) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C5004
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Takara Holdings Inc (2531) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Takara Holdings Inc (Takara) is a holding company that coordinates and controls the management of all its group companies. The group comprises Takara Shuzo Group, Takara Bio Group and Takara Healthcare. The Takara Shuzo group offers alcoholic beverages and seasonings; the Takara Bio group develops biomedicals and the Takara Healthcare group provides health foods such as fucoidan, developed with Hokkaido Gagome kombu kelp extracts. Takara offers shochu, sake, light-alcohol refreshers, wine, whisky, Chinese alcoholic beverages, seasonings, raw alcohol, gene and cell therapies and health foods among others. It operates along with its subsidiaries in Japan, the US, China, and Europe. Takara is headquartered in Shimogyo-Ku, Kyoto, Japan.

Takara Holdings Inc Key Recent Developments

Jul 27,2017: Takara Holdings: Consolidated Financial Statements for the First Quarter Ended June 30, 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Takara Holdings Inc – Key Facts 6
Takara Holdings Inc – Key Employees 7
Takara Holdings Inc – Key Employee Biographies 8
Takara Holdings Inc – Major Products and Services 9
Takara Holdings Inc – History 11
Takara Holdings Inc – Company Statement 13
Takara Holdings Inc – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
Takara Holdings Inc – Business Description 16
Business Segment: Other 16
Overview 16
Performance 16
Business Segment: Takara Bio Group 16
Overview 16
Performance 16
Business Segment: Takara Shuzo Group 16
Overview 16
Performance 17
Business Segment: Takara Shuzo International Group 17
Overview 17
Performance 17
R&D Overview 17
Takara Holdings Inc – Corporate Strategy 18
Takara Holdings Inc – SWOT Analysis 19
SWOT Analysis – Overview 19
Takara Holdings Inc – Strengths 19
Takara Holdings Inc – Weaknesses 20
Takara Holdings Inc – Opportunities 21
Takara Holdings Inc – Threats 22
Takara Holdings Inc – Key Competitors 23
Section 3 – Company Financial Ratios 24
Financial Ratios – Capital Market Ratios 24
Financial Ratios – Annual Ratios 25
Performance Chart 28
Financial Performance 28
Financial Ratios – Interim Ratios 29
Financial Ratios – Ratio Charts 30
Section 4 – Company’s Lifesciences Financial Deals and Alliances 31
Takara Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Takara Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32
Takara Holdings Inc, Recent Deals Summary 33
Section 5 – Company’s Recent Developments 34
Jul 27, 2017: Takara Holdings: Consolidated Financial Statements for the First Quarter Ended June 30, 2017 34
Section 6 – Appendix 36
Methodology 36
Ratio Definitions 36
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Takara Holdings Inc, Key Facts 6
Takara Holdings Inc, Key Employees 7
Takara Holdings Inc, Key Employee Biographies 8
Takara Holdings Inc, Major Products and Services 9
Takara Holdings Inc, History 11
Takara Holdings Inc, Subsidiaries 14
Takara Holdings Inc, Key Competitors 23
Takara Holdings Inc, Ratios based on current share price 24
Takara Holdings Inc, Annual Ratios 25
Takara Holdings Inc, Annual Ratios (Cont...1) 26
Takara Holdings Inc, Annual Ratios (Cont...2) 27
Takara Holdings Inc, Interim Ratios 29
Takara Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Takara Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32
Takara Holdings Inc, Recent Deals Summary 33
Currency Codes 36
Capital Market Ratios 36
Equity Ratios 37
Profitability Ratios 37
Cost Ratios 38
Liquidity Ratios 38
Leverage Ratios 39
Efficiency Ratios 39

List of Figures
Takara Holdings Inc, Performance Chart (2014 - 2018) 28
Takara Holdings Inc, Ratio Charts 30
Takara Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Takara Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 32

★海外企業調査レポート[Takara Holdings Inc (2531):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Valeo S.A.:企業の戦略・SWOT・財務分析
    Valeo S.A. - Strategy, SWOT and Corporate Finance Report Summary Valeo S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Orpea SA (ORP):企業の財務・戦略的SWOT分析
    Summary Orpea SA (Orpea) is a healthcare consulting company that offers clinical care services. The company provides services such as suite care clinic services, retirement homes, and mental hospital services, among others. Its mental hospital services include treatment of mood disorders, overuse sy …
  • Royal Mail plc (RMG):企業の財務・戦略的SWOT分析
    Royal Mail plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • The National Commercial Bank
    The National Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary The National Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Osprey Medical Inc (OSP)-医療機器分野:企業M&A・提携分析
    Summary Osprey Medical Inc (Osprey Medical) is a medical device company that designs, develops, and manufacturers proprietary devices and monitoring systems. The company provides contrast removal system, which is designed to provide cardiologists with an advanced level of CIN protection in high risk …
  • Black Box Corp (BBOX):企業の財務・戦略的SWOT分析
    Black Box Corp (BBOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • J.W. Ostendorf GmbH & Co KG:企業の戦略・SWOT・財務情報
    J.W. Ostendorf GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary J.W. Ostendorf GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Banco Santander (Brasil) SA:企業の戦略・SWOT・財務情報
    Banco Santander (Brasil) SA - Strategy, SWOT and Corporate Finance Report Summary Banco Santander (Brasil) SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Biocept Inc (BIOC):医療機器:M&Aディール及び事業提携情報
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • BrainCool AB (BRAIN):企業の製品パイプライン分析2018
    Summary BrainCool AB (BrainCool), a subsidiary of Dignitana AB, is a medical device company that focuses on developing, and commercializing medical cooling systems for brain cooling and pain management. The company’s products are based on the principle that applying therapeutic hypothermia contribut …
  • Trafigura Group Pte Ltd:企業の戦略的SWOT分析
    Trafigura Group Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • GDS Holdings Ltd (GDS):企業の財務・戦略的SWOT分析
    GDS Holdings Ltd (GDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Assicurazioni Generali SpA:戦略・SWOT・企業財務分析
    Assicurazioni Generali SpA - Strategy, SWOT and Corporate Finance Report Summary Assicurazioni Generali SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • MiMedx Group Inc (MDXG)-医療機器分野:企業M&A・提携分析
    Summary MiMedx Group Inc (MiMedx) is a provider of bioactive healing products for tissue regeneration. The company’s products are used in the therapeutic areas of chronic wounds, dental, ophthalmology, spine, orthopedic surgery, sports medicine and urology. Its products help in reducing inflammation …
  • TAS S.p.A. (TAS):企業の財務・戦略的SWOT分析
    TAS S.p.A. (TAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Viamet Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Viamet Pharmaceuticals Inc (Viamet), a subsidiary of Viamet Pharmaceuticals Holdings LLC, discovers and develops novel medicinal drugs based on metalloenzyme chemistry and biology technology platform. Its product pipeline includes clinical-stage compounds such as VT-1161, an oral inhibitor u …
  • Thermo Fisher Scientific Inc (TMO):企業の財務・戦略的SWOT分析
    Thermo Fisher Scientific Inc (TMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Mastech Digital Inc (MHH):企業の財務・戦略的SWOT分析
    Summary Mastech Digital Inc (Mastech) operates as an IT staffing company that offers digital transformation services. The company offers services such as database administration, middleware, business analytics and QA, data warehousing, admin desktop fiac, and project management services, among other …
  • Rum Group for Transportation & Tourism Investment:戦略・SWOT・企業財務分析
    Rum Group for Transportation & Tourism Investment - Strategy, SWOT and Corporate Finance Report Summary Rum Group for Transportation & Tourism Investment - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • Varian Medical Systems Inc (VAR):企業の財務・戦略的SWOT分析
    Varian Medical Systems Inc (VAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆